BioPort 2019 Schedule

Wednesday November 7th, 2018
Registration (Light breakfast provided)
9:00am – 9:30am

BIC Junior (Open to the public)
Budding life science entrepreneurs in Nova Scotia pitch their business ideas to a panel of judges. (high school & first-year post-secondary students)
Host: Jeremie Saunders, Founder/Host of Sickboy Podcast
9:30am – 12:00pm

Jeremie Saunders

Jeremie Saunders

Keynote Speaker

Founder of Sickboy Podcast

Biography

Jeremie is an award-winning actor, producer and host of popular original Canadian media, including film, television and podcasts. He lives with a genetic lung disease called Cystic Fibrosis.

Jeremie was born and raised on the East Coast of Canada. After discovering his passion for performance through competitive improv, he was accepted into the acting program at Ryerson Theatre School. Soon after, Jeremie began his career as a professional actor. He hosted the Gemini and Canadian Screen Award-winning CBC children’s television series “ARTZOOKA!” and the National Film Board of Canada’s educational documentary series “Space School”.

In the culmination of Jeremie’s affinity for laughter and education, Sickboy Podcast was founded. Listed as one of iTunes Best Of 2015, Sickboy Podcast is produced and hosted by Jeremie and his two best friends Taylor MacGillivary and Brian Stever. Together they explore conversations with a wide range of guests, talking and laughing about the experiences of living with terminal or chronic illness. Sickboy Podcast aims to tear down the walls of stigma and find levity in an otherwise dark situation.

Jeremie is a brilliant speaker, his keynotes having been described as “simply the most thought-provoking, powerful talk I’ve ever witnessed.” CBC released an acclaimed documentary on Sickboy in October 2017, just weeks before Jeremie gave a rousing standing ovation for his talk at TEDxToronto.

Jeremie is currently based out of Halifax Nova Scotia where he lives with his wife Bryde and their oversized muffin of a dog, Bigby.

Lunch Break (on your own)
12:00pm – 1:30pm

The BioInnovation Challenge (Open to the public)
Semi-finalists will pitch to a panel of judges to determine the top three finalists to go on stage during the BioPort conference on Thursday, November 8th.
Host: Dr. Corinna Lathan, Brain Scientist, Technology Pioneer, Founder & CEO, Anthrotronix
1:30pm – 5:00pm

Dr. Corinna Lathan

Dr. Corinna Lathan

Evening Keynote Speaker

CEO of AnthroTronix, Inc.

Biography

Dr. Corinna Lathan, CEO of AnthroTronix, Inc., will provide an evening keynote address to health and life sciences innovators, industry leaders, and investors from across North America during BioPort 2018, on November 7-8, at the Halifax Convention Centre. Dr. Lathan’s keynote address will explore the transformative impact of technology on life sciences companies and health care.

Dr. Lathan is a neuroscientist, engineer, and health technology entrepreneur. Her company has successfully developed an FDA-cleared mobile platform for healthcare providers to assess cognitive function. She has also developed robotics for kids with disabilities, virtual reality technology for the Space Station (NASA), and wearable sensors for training surgeons and soldiers. These human-technology innovations have been featured in Forbes and Time magazines and led to Dr. Lathan being named as MIT Technology Review Magazine’s ‘Top 100 World Innovators’.

Since 1999, Dr. Lathan has served as the founder, CEO, and Board Chair of AnthroTronix Inc., a biomedical engineering research and development company creating diverse human-centered products in digital health, wearable technology, robotics, and augmented reality.  The company recently developed FDA-cleared, mobile digital health software platform DANA™. This work lead Dr. Lathan to be named ‘2017 Woman to Watch’ by Disruptive Women in Health Care.

Dr. Lathan is an advocate for STEM educational outreach programs and started her own in 1992 called Keys to Empowering Youth. She has also coached for the FIRST and VEX robotics program and advised the Smithsonian Institute’s Lemelson Center for the Study of Invention and Innovation. Dr. Lathan sits on the boards of many innovative organizations such as the KID Museum Makerspace and Engineering World Health.

Dr. Lathan will be speaking at BioPort 2018, Nova Scotia’s premiere Health and Life Sciences event hosted by BioNova, on November 7th, at 6pm ADT at the Halifax Convention Centre.

Welcome Reception presented by Grant Thornton
Join us to open BioPort – For all conference attendees and Keynote ticket holders, an opportunity to meet and network.
5:00pm – 6:00pm

Kick-off Keynote: Dr. Corinna Lathan, Brain Scientist, Technology Pioneer, Founder & CEO, Anthrotronix
Talk: The Future of Health
Individual tickets for Welcome Reception and Kick-off Keynote available
6:00pm – 7:30pm

Dr. Corinna Lathan

Dr. Corinna Lathan

Evening Keynote Speaker

CEO of AnthroTronix, Inc.

Biography

Dr. Corinna Lathan, CEO of AnthroTronix, Inc., will provide an evening keynote address to health and life sciences innovators, industry leaders, and investors from across North America during BioPort 2018, on November 7-8, at the Halifax Convention Centre. Dr. Lathan’s keynote address will explore the transformative impact of technology on life sciences companies and health care.

Dr. Lathan is a neuroscientist, engineer, and health technology entrepreneur. Her company has successfully developed an FDA-cleared mobile platform for healthcare providers to assess cognitive function. She has also developed robotics for kids with disabilities, virtual reality technology for the Space Station (NASA), and wearable sensors for training surgeons and soldiers. These human-technology innovations have been featured in Forbes and Time magazines and led to Dr. Lathan being named as MIT Technology Review Magazine’s ‘Top 100 World Innovators’.

Since 1999, Dr. Lathan has served as the founder, CEO, and Board Chair of AnthroTronix Inc., a biomedical engineering research and development company creating diverse human-centered products in digital health, wearable technology, robotics, and augmented reality.  The company recently developed FDA-cleared, mobile digital health software platform DANA™. This work lead Dr. Lathan to be named ‘2017 Woman to Watch’ by Disruptive Women in Health Care.

Dr. Lathan is an advocate for STEM educational outreach programs and started her own in 1992 called Keys to Empowering Youth. She has also coached for the FIRST and VEX robotics program and advised the Smithsonian Institute’s Lemelson Center for the Study of Invention and Innovation. Dr. Lathan sits on the boards of many innovative organizations such as the KID Museum Makerspace and Engineering World Health.

Dr. Lathan will be speaking at BioPort 2018, Nova Scotia’s premiere Health and Life Sciences event hosted by BioNova, on November 7th, at 6pm ADT at the Halifax Convention Centre.

Thursday, November 8th, 2018
Registration(Light breakfast provided)
7:30am – 8:00am
Welcome and Opening Address
Join us as members of government discuss the value of the Health and Life Science Sector.
8:30am – 9:30am

BioInnovation Challenge - Final Presentations
The top three finalists will present to the judges and the audience to determine the winner, announced at the end of day.
9:30am - 10:30am

Brett Dickey, PhD

Brett Dickey, PhD

BIC Host

Co-Founder & CTO of Covina Biomedical Inc.

Biography

Brett is a co-founder and CTO of Covina Biomedical Inc., an orthopaedic device start-up developing new biomaterials for use in minimally invasive treatments to enhance surgeon efficiency and maximize patient outcomes. Brett earned a Bachelor’s degree in Mechanical Engineering (2010) and subsequently his Doctorate in Biomedical Engineering (2016) from Dalhousie University. His PhD research investigated adaptations to the chemistry of glass-based cements with a goal to expand their use beyond their traditional dental market and into the $1B orthopaedic bone cement market. It was this research that became the foundation for Covina’s technology platform to stabilize both bone fractures and orthopaedic implants. Brett has made 18 contributions to the scientific literature, is co-inventor on three granted patents, and was a finalist in the Emerging Professional category at the 2016 Discovery Awards. After winning the 2015 BioInnovation Challenge, Covina has gone on to be selected for the prestigious Canadian Technology Accelerator program in Boston, has won several awards in pitch competitions throughout Massachusetts, and has raised over $1.6m in equity and non-dilutive funding.

Networking Break (B2B Meetings)
10:30am – 11:00am
Concurrent Session #1: Emerging Natural Products of Atlantic Canada supported by Natural Products Canada
Join us for a discussion on the ecosystem of expertise, resources, and investment that bolsters commercialization in Atlantic Canada’s natural products industry.

Moderated by Stephen Ball, MSc, MBA (Regional Director, NPC-Atlantic)
Panel 1: Value of Medical Cannabis in the Health Market
Panelists: Dr. Bob Chapman, Dr. Bill Cheliak, Dr. Christian Lehmann

Panel 2: Focusing our Natural Products Market Potential
Panelists: Dr. Beth Mason, Tracey Allen
Tracey Allen

Tracey Allen

Panelist

Vice President Finance, Nature’s Way of Canada

Biography

Tracey has 20 years of experience as a financial professional and business advisor leading organizations to successfully pursue their growth agendas. She is currently Vice President Finance at Nature’s Way Canada and has spent time in the heavy equipment and telecommunications industries.

Tracey holds a Bachelor of Commerce from Memorial University of Newfoundland where she was born and raised and is a member of the Chartered Professional Accountants of Nova Scotia. Outside of work she is passionate about youth sports and in particular keeping girls in sports. She is an active volunteer as a coach and manager and serves on the Board of the Harbour City Lakers ringette association.

Dr. Beth Mason

Dr. Beth Mason

Panelist

CEO, Verschuren Centre for Sustainability in Energy & the Environment Cape Breton University

Biography

Dr. Mason came to the Verschuren Centre, Cape Breton, four years ago, to build the bio-products research program, after working with Saputo Dairy Products Canada for 11 years prior, as well as running her own by-products logistics business. Her background brings a mix of industry, research, government, and business approaches to problem solving in the Agri-food and marine industries, specifically by-product value extraction and production of functional ingredients for feed, plant, and food. The program activities range from bench through pilot bio-transformations of products as diverse as fish, shellfish, and poultry by-products, and aims to assist companies with product development, process optimization and commercialization in the marine, aquaculture, and agriculture sectors. As CEO of the VC for the last year, Dr. Mason and team have expanded the VC engagement in renewable energy, specifically thermal energy conversion, recovery, and storage. The VC is unique in its capacity to bring together large industry and community partners toward development and demonstrations of innovative clean tech solutions for renewable energy storage, carbon sequestration, bio-transformations, and aquaculture.

Dr. Christian Lehmann

Dr. Christian Lehmann

Panelist

Clinical Researcher, Dalhousie

Biography

Dr. Christian Lehmann is Professor of Anesthesia, Pharmacology, Microbiology & Immunology and Physiology & Biophysics at Dalhousie University, Halifax, NS. He is Staff Anesthesiologist and Associate Medical Director of Research in the Department of Anesthesia, Pain Management and Perioperative Medicine, Nova Scotia Health Authority, Halifax. Dr. Lehmann has 25 years of experience in experimental and clinical inflammation research including studies on the mechanisms of pain. He is the author of morethan 150 original publications, 5 books, 13 book chapters, and almost 200 published abstracts. In 2009 he founded the RESIST (Research in the Endocannabinoid System in Inflammation, Sepsis and Trauma) group with Dr. Melanie Kelly (Pharmacology) and others at Dalhousie. He and his collaborators received funding for their research on the therapeutic modulation of the endogenous cannabinoid system and for related research projects from CIHR, NSERC, CFI, MITACS, NSHRF, and Innovacorp. Dr. Lehmann is co-founder of Panag Pharma Inc. – a Halifax-based company working on novel cannabinoid formulations for the treatment of pain and inflammation.

Dr. Bill Cheliak

Dr. Bill Cheliak

Panelist

CEO, Panag Pharmaceuticals

Biography

Bill has over 20 years of business experience in a wide variety of biotechnology fields, including vaccines, human genetics, drug development, manufacturing and extensive interactions with the pharmaceutical industry. Over the past 15 years, Bill has been involved in business development in the biotechnology sector with both private and publicly traded companies. He has executed numerous technology deals with Pharma, academic institutions and hospitals as well as securing financing ($150M+) for various companies with many venture firms. Bill currently serves on the Board of Directors of a publicly traded company on the TSX. He has a PhD in Genetics.

Dr. Bob Chapman

Dr. Bob Chapman

Panelist

Chief Operating Officer, DoseCann Inc.

Biography

Dr. Chapman has been applying his broad practical experience in organic and analytical chemistry for the past nineteen years to solve problems of industrial relevance. Most recently, Dr. Chapman was a Principal Research Officer with the National Research Council Canada (͞”NRC”) ACRD Research Centre where he was responsible for leading a national program and strategic projects focused on the development of Natural Health Products and functional ingredients with private sector companies which led to research on cannabinoid-based mixtures. For NRC, he also served on national advisory committees supporting the standardization needs for the emerging cannabis industry to ensure quality and safety of cannabis supply. Prior to the NRC, Dr. Chapman spent 6 years working as a Senior Scientist for bioscience start-up companies in San Francisco, California. Dr. Chapman is also the Vice-President of the NHP Research Society and the recording secretary for the processing and handling subcommittee for ASTM D37.04 standards group on cannabis. Dr. Chapman is an active member of the Canada’s bioscience community serving on several boards and advisory boards. He holds a Ph.D. in Organic Chemistry from the University of British Columbia, has published widely, holds several patents, and has presented at numerous scientific symposia.

Stephen Ball, MSc, MBA

Stephen Ball, MSc, MBA

Moderator

Regional Director, NPC-Atlantic

Biography

Stephen is a forward-thinking, strategic problem solver with over 12 years in the international innovation space. With a background in biochemistry, Stephen has built this career on his scientific knowledge, fueled by his desire to use science to create real-world solutions.

Most recently, Stephen was Director of Sales and Marketing at BioVectra, a contract manufacturing company serving a global client base. There, he gained extensive understanding of various manufacturing processes such as fermentation, and their role in new product development. He was also exposed to the regulatory requirements of Good Manufacturing Practices, Environment Canada, Health Canada, and the FDA. Most importantly, he garnered a reputation for developing mutually-beneficial business relationships with clients and partners, helping the company significantly expand its market share.

Stephen was responsible for over $100 million in sales, providing extensive insight and leadership to project teams to ensure their viability. He also led corporate and academic research teams through the commercialization process, helping them manage issues in research, navigate regulatory compliance requirements, and negotiate intellectual property agreements.

Stephen has a BSc from Mount Allison, and received his MSc at Memorial University. He completed his MBA with a concentration in marketing at Saint Mary’s University.

Concurrent Session #2: Solutions for Health Innovation
The value of health innovation is about more than just cutting costs, it’s about outcomes for patients, physicians and our health system. Join us to learn how a group of healthcare innovators are working to empower the region’s healthcare system to adopt new health innovations made in our own backyard and transform them into an economic driver.
11:00am – 12:00pm

Moderated by Paul Bradley (President, MedTech Consulting Inc.)
Panelists: Dr. Bob Abraham, Jocelyn Hiltz, Dr. Krista Jangaard

Dr. Krista Jangaard

Dr. Krista Jangaard

Panelist

President & CEO, IWK Health Centre

Biography

Dr. Krista Jangaard is the IWK Health Centre’s President & CEO. Krista first joined the IWK in 1996 in the division of Neonatal-Perinatal Medicine. In 2008, she assumed the role of Medical Director of the Neonatal Intensive Care Unit and in 2010 became the Neonatal-Perinatal Medicine Division Head. In addition, Krista is an associate professor at Dalhousie University in the department of pediatrics and the department of obstetrics and gynecology.

Krista completed her medical training at Dalhousie University where she also later earned a Masters of Health Administration and was awarded the Glenn Moore Memorial Award and the Nova Scotia Association of Health Organizations Award for Academic Excellence. Krista is a mother of two, lives in Halifax with her husband and dog, and is an avid gardener.

Jocelyn Hiltz

Jocelyn Hiltz

Panelist

Account Manager, Atlantic Canada Opportunities Agency (ACOA) – Atlantic Innovation Fund (AIF) Program and Business Development Program (BDP)

Biography

Dr. Bob Abraham

Dr. Bob Abraham

Panelist

President, Chief Executive Officer, Founder & Director, ABK Biomedical Professor, Department of Diagnostic Radiology, Dalhousie University

Biography

Dr. Abraham has been a practicing clinician and Interventional Radiologist (IR) for over 20 years. Dr. Abraham graduated from Dalhousie University’s Medical School in 1987. After completing his Rotating Internship at St. Paul’s Hospital in Vancouver, he returned for specialty training in Diagnostic Imaging at Dalhousie University from 1988 to 1992. He subsequently completed subspecialty training in Interventional Radiology at the Royal Melbourne Hospital in Australia in 1993. He returned to Dalhousie University as Attending Staff and is Full Professor at the Medical School. Dr. Abraham has a track record of licensed catheter innovations, granted patents and is actively engaged in funded research projects with funding to date, totaling in excess of $4 million. Dr. Abraham’s primary clinical expertise and research interests are in bland embolization, Y-90 Radioembolization, Chemoembolization, Arterial and Venous Angioplasty / Intravascular Stenting and endovascular treatment of complex thoracic and abdominal aortic aneurysms (Fenestrated and Branched Stent Graft Deployment). Dr. Abraham is a recognized leader in Canada and recently completed his tenure as Chair of the Royal College of Physicians and Surgeons of Canada Examination in Diagnostic Radiology and as President of the Canadian Association of Interventional Radiologists (CIRA). Dr. Abraham was honored as a Fellow of the Society of Interventional Radiology (FSIR) in 2016 for his outstanding contributions and achievements in Interventional Radiology and he was recently profiled in Interventional News (https://interventionalnews.com/bob-abraham/). ​

Paul Bradley

Paul Bradley

Panelist

President, MedTech Consulting Inc. Former VP of Strategic Affairs, Johnson & Johnson

Biography

Paul Bradley is a healthcare industry executive with over 30 years experience in the Canadian medical device and pharmaceutical markets. He has held leadership roles in a wide range of functional areas at Johnson & Johnson including sales, marketing, strategic account management, human resources, and operations. As Vice President of Strategic Affairs Paul had leadership responsibility for health economics and market access, professional education, clinical and regulatory affairs, quality, health care compliance, and was a member of the Management Board. Paul is also a leader within the Canadian medical device industry, serving on the MEDEC Board from 2009 to 2016 holding various leadership roles over that time including Treasurer, Executive Team Member, and Board Chair for the final two years. Paul is currently a Board member and Treasurer at ventureLAB, York Region’s Regional Innovation Centre, and is a member of the Ontario Health Technology Advisory Committee (OHTAC). Paul is President of MedTech Consulting where he works with small and medium sized companies in the area of business development.

Lunch Reception
12:00pm – 12:45pm

Keynote Luncheon: Jeremie Saunders, Founder and Host of Sickboy Podcast
Talk: The Need for Continued Health Innovation
12:45pm – 2:00pm

Jeremie Saunders

Jeremie Saunders

Keynote Speaker

Founder of Sickboy Podcast

Biography

Jeremie is an award-winning actor, producer and host of popular original Canadian media, including film, television and podcasts. He lives with a genetic lung disease called Cystic Fibrosis.

Jeremie was born and raised on the East Coast of Canada. After discovering his passion for performance through competitive improv, he was accepted into the acting program at Ryerson Theatre School. Soon after, Jeremie began his career as a professional actor. He hosted the Gemini and Canadian Screen Award-winning CBC children’s television series “ARTZOOKA!” and the National Film Board of Canada’s educational documentary series “Space School”.

In the culmination of Jeremie’s affinity for laughter and education, Sickboy Podcast was founded. Listed as one of iTunes Best Of 2015, Sickboy Podcast is produced and hosted by Jeremie and his two best friends Taylor MacGillivary and Brian Stever. Together they explore conversations with a wide range of guests, talking and laughing about the experiences of living with terminal or chronic illness. Sickboy Podcast aims to tear down the walls of stigma and find levity in an otherwise dark situation.

Jeremie is a brilliant speaker, his keynotes having been described as “simply the most thought-provoking, powerful talk I’ve ever witnessed.” CBC released an acclaimed documentary on Sickboy in October 2017, just weeks before Jeremie gave a rousing standing ovation for his talk at TEDxToronto.

Jeremie is currently based out of Halifax Nova Scotia where he lives with his wife Bryde and their oversized muffin of a dog, Bigby.

Networking Break (B2B Meetings)
2:00pm – 2:30pm
The Tech Revolution Reshaping Health
We are at the cusp of change in the way health services in Canada are delivered. Disruptive health technologies bring transformational improvements in the affordability, accessibility, quality and simplicity of health care solutions. Join us to hear from industry leaders how tools such as Artificial Intelligence (AI), robotics, Virtual Reality (VR) and Augmented Reality (AR) are revolutionizing and reshaping health.
2:30pm – 4:00pm

Moderated by Miriam Zitner (Vice President, Halifax Innovation District)
Presenting Speaker: Allan Miranda
Panelists: Ryan Cameron, Dr. Steven Beyea, Chris Crowell, Brian Thompson

Miriam Zitner

Miriam Zitner

Moderator

Vice President Halifax Innovation District

Biography

Miriam Zitner is leading the three-year master plan to develop and advance Halifax’s Innovation District, working in collaboration with the private sector, our universities and the community college, Nova Scotia’s MIT REAP team and Halifax’s start-up and innovation centres.

Miriam has 20 years experience working with Fortune 100 technology companies and start-ups, primarily out of Toronto and Vancouver, focused on photonics, biometrics and energy. Companies such as IBM (B2B), Intel (B2C and B2B, channel sales), Microsoft (B2C, some B2B), and  MSN.CA.  She has also worked with academic institutions and associations and understands the operating framework of collaborating with many constituents that share a desired outcome.

Miriam’s ability to understand and translate complex ideas into easily understood ideas, alongside her experience working with Canadian subsidiaries of American companies, as well as start-ups in various stages of maturation, lends itself well to the Partnership’s goal of attracting large, established businesses to the region as well as fostering the growth of Halifax companies.
Allan Miranda

Allan Miranda

Presenting Speaker

Head of JLABS @ Canada

Biography

As Head of Johnson & Johnson Innovation, JLABS in Canada, Allan is responsible for external engagement, innovation sourcing, company onboarding, portfolio management, operational excellence, educational programming and P&L. He catalyzes and supports the translation of science and technology into valuable solutions for patients and consumers across the pharmaceutical, medical device, consumer and healthtech sectors.

Allan joined the JLABS team from Janssen Canada, where he has spent the last 12 years in positions of increasing responsibility in business development, marketing and market access. His most recent role was Therapeutic Lead Immunology and Primary Care where he was responsible for market access strategy for a complex product portfolio exceeding $1 billion. Allan started his career at PARTEQ Innovations, the technology transfer arm of Queen’s University at Kingston where he was responsible for technology assessment and new company start-up. He then moved to Paladin Labs, where he successfully completed numerous in-licensing transactions for specialty pharmaceutical products for the Canadian market. Allan subsequently worked in business development for two early stage biotechnology companies in Canada leading their business development and partnering initiatives prior to joining Janssen.

Allan received his Ph.D. in Neuropharmacology from Queen’s University at Kingston, Ontario and his MBA from McGill University in Finance and Strategy.

Ryan Cameron

Ryan Cameron

Panelist

CEO, Electric Puppets

Biography

Ryan Cameron has been a serial innovator since 1997. In 2000, Ryan led a team to create the first interactive versions of the beloved Little Golden Books for Disney Interactive, and then became CTO of an international US based firm that delivered online education to fortune 100 corporate employees. Ryan was CTO of online educational companies for the next 10 years before starting his own innovativeonline educational company, and advised on international boards and organizations as well. Ryan created online educational products that won numerous awards and helped hundreds of thousands of fortune 500 employees learn important new skills in multi-year award winning online programs. Ryan joined Copernicus Studios in 2013 and led the interactive division to create one of the first speech recognition engines tuned to children’s voices to empower early literacy applications, and then founded Electric Puppets in 2016. Ryan is an avid rare book and antique collector and lives on an acreage in Chester, Nova Scotia.

Dr. Steven Beyea

Dr. Steven Beyea

Panelist

Scientific Program Lead, Biomedical Translational Imaging Centre (BIOTIC)

Biography

Steven Beyea is the Scientific Program Lead for the Biomedical Translational Imaging Centre (BIOTIC), which is a research centre of both the IWK and QEII Health Centres. He is also a Professor of Diagnostic Radiology, Physics, Biomedical Engineering, and Health Sciences at Dalhousie University. His research focuses on the development of novel medical imaging technologies and their clinical/commercial translation. This work has attracted >$6M in research grants/awards as principal investigator since 2014. In particular he leads a number of large scale projects, in collaboration with industry partners such as GE Healthcare, which utilize Artificial Intelligence in the development of potentially disruptive technologies for improved health outcomes.

Chris Crowell

Chris Crowell

Panelist

VP of Corporate Innovation, Volta

Panelist

Chris is Volta’s Vice President of Corporate Innovation. He is responsible for helping corporate and public sector partners leverage the startup ecosystem to drive innovation in their own organizations through Volta’s Outpost Program. Prior to joining Volta, Chris served as the CMO for Mariner Partners. He also spent time working with OpenText in Waterloo leading the worldwide technology partners team and with Bell Canada in Toronto, focusing on innovation strategy and managing the consumer market operations P&L. Chris holds a degree in Mass Communications from Carleton University and a L.L.B and MBA from Dalhousie University where he was a past recipient of the Outstanding Young Alumnus for his work as founder of East Coast Connected and organizer of the Atlantic Business Summits.

Brian Thompson

Brian Thompson

Panelist

CEO, Dalhousie Medical Research Foundation

Biography

Brian Thompson joined the Dalhousie Medical Research Foundation (DMRF) in September 2016 as its first CEO. The Foundation has grown in size and scope under Brian’s leadership building on its nearly forty-year history supporting medical research at Dalhousie’s Faculty of Medicine. Now with a team of thirteen, DMRF raises much needed funds for all areas of health research. Collaboration is key to the Foundation’s success as they partner very closely with Dalhousie University and other key health partners in the region. Brian is a native Montrealer, graduate of McGill University, and is fluently bilingual.

Announcement of the BioInnovation Challenge Winner and Closing Reception
4:00pm – 5:00pm